Handmade quality · Free shipping over $75 · Explore the atelier

XCC l 3-O-β-D-glucoside The Phase I clinical study

SKU: 69068097504

4.8
USD100.00 USD123.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 28 - Aug 2

Description

The Phase I clinical study shows that after intravenous infusion of 80

InChi: InChI=1S/C30H40O4/c1-18-19-8-9-22-28(4

Redox Biology

PKCß inhibitor

XCC l 3-O-β-D-glucoside The Phase I clinical studyProduct information CAS Number: 96865 83 7 Molecular Weight: 386. 40 Formula: C19H22N4O5 Chemical Name: 2 [4 (2,6 dioxo 1,3 dipropyl 2,3,6,7 tetrahydro 1H purin 8 yl)phenoxy]acetic acid Smiles: CCCN1C(=O)C2NC(=NC=2N(CCC)C1=O)C1C=CC(=CC=1)OCC(O)=O InChiKey: QTMMGCYGCFXBFI UHFFFAOYSA N InChi: InChI=1S C19H22N4O5 c1 3 9 22 17 15(18(26)23(10 4 2)19(22)27)20 16(21 17)12 5 7 13(8 6 12)28 11 14(24)25 h5 8H,3 4,9 11H2,1 2H3,(H,20,21)(H,24,25) Technical Data

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products